Treatment of Spastic Paresis
- 8 June 1989
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 320 (23) , 1553-1555
- https://doi.org/10.1056/nejm198906083202310
Abstract
Whenever the central nervous system is damaged, two types of symptoms and signs emerge. Negative ones, such as weakness, paralysis, fatigability, and lack of dexterity, result from either disconnection of lower motor neurons in the brain stem and spinal cord from the cerebral motor system or destruction of the neurons themselves. The second type — positive symptoms and signs — includes excessive involuntary motor activity usually associated with macroscopic lesions of the central nervous system and referred to as spasticity. Disconnection of lower motor neurons from cerebral control releases lower-level circuits, which then become overactive and produce dramatic patterns of . . .Keywords
This publication has 11 references indexed in Scilit:
- Intrathecal Baclofen for Severe Spinal SpasticityNew England Journal of Medicine, 1989
- Microsurgical DREZ-otomy for the Treatment of Spasticity and Pain in the Lower LimbsNeurosurgery, 1989
- Intrathecal Baclofen for Severe SpasticityAnnals of the New York Academy of Sciences, 1988
- Role of Epidural and Intrathecal Narcotics and Peptides in the Management of Cancer PainMedical Clinics of North America, 1987
- Actions of opioids on primate spinothalamic tract neuronsJournal of Neuroscience, 1986
- INTRATHECAL BACLOFEN IN TETANUSThe Lancet, 1986
- Pre- and postsynaptic effects of baclofen in the rat hippocampal sliceBrain Research, 1985
- Control of Spasticity by Implantable Continuous Flow Morphine PumpNeurosurgery, 1985
- Selenium: A Case for Its Essentiality in ManNew England Journal of Medicine, 1981
- An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesionsNeurology, 1976